Daniel Alfaro III MD in Charleston, South Carolina

Home South Carolina Charleston

Daniel Alfaro III MD has Ophthalmology as his primary medical specialty. Their primary office is: 3531 Mary Ader Ave in Charleston, South Carolina. There is an additional office location, for a total of two, for Daniel Alfaro III MD that can be viewed further down.

They're a part of the: Charleston Neurosciences Institute medical group which has around 5 members. You can call their office at 843-763-4466 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Js Weill Medical College, Cornell University and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Daniel D Alfaro III MD Office Phone and Directions

Daniel Alfaro III MD
Charleston Neurosciences Institute
3531 Mary Ader Ave
Charleston, South Carolina 29414
843-763-4466

Patient Ratings
Please rate your experience with Daniel Alfaro III MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 843-763-4466

Enter a starting address:

Healthcare Info for Daniel Alfaro III MD

Medical School: Js Weill Medical College, Cornell University
Graduation Year: 1988
The Primary Medical Specialty for Daniel Alfaro III MD is listed as: Ophthalmology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 36
PAC (PECOS ID)#: 3678461787
NPI #: 1982719290
NPI Created On: 08/20/2006
NPI Last Updated Listed as: 06/08/2020
Primary Taxonomy Code: 207W00000X
License Number:
191107
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Absolute Total Care, Inc
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, SPANISH; CASTILIAN.

Services and Procedures include:

Injection of drug into eye
Removal of eye fluid (vitreous) between the lens and retina
Laser destruction of eye fluid (vitreous) between the lens and retina
Removal of membrane from the retina, pars plana approach
Repair of detached retina and drainage of eye fluid between lens and retina
Eye and medical examination for diagnosis and treatment, new patient
Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
Eye and medical examination for diagnosis and treatment, established patient
Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
Diagnostic imaging of retina
Imaging of blood vessels in back of eye using fluorescein dye
Photography of the retina
New patient office or other outpatient visit, typically 45 minutes
Injection, ranibizumab, 0.1 mg
Injection, dexamethasone, intravitreal implant, 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 797061539

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: TEPEZZA

Name of Drug #1: TEPEZZA

Open Associated Drug #1: 75987-130-15

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792685497

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792685499

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GLAUCOMA

Name of Drug #1: DURYSTA

Open Associated Drug #1: 0023-9652-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792685501

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: GLAUCOMA

Name of Drug #1: DURYSTA

Open Associated Drug #1: 0023-9652-01

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792685503

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792685505

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07

Payments Total: $112

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835900545

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835900533

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835900525

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01

Drug or Biological: Biological

Product Category #2: Immunology and Ophthalmology

Name Of Drug #2:: SUSVIMO

Associated Drug #2: 50242-078-12

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835900527

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01

Additional Office Locations

1. Charleston Neurosciences Institute
9565 Hwy 78 300
Ladson, SC 29456
Group Members: 5

Phone: 843-763-4466

Enter a starting address:

Ophthalmology Professionals in Charleston

1.
Michael Johnson MD

3531 Mary Ader Ave
Charleston, SC
Charleston Neurosciences Institute

2.
Laura Wilbanks

171 Ashley Ave
Charleston, SC
University Medical Associates

3.
Eric Jablon MD

3531 Mary Ader Ave
Charleston, SC
Charleston Neurosciences Institute

4.
Robert House

2270 Ashley Crossing Dr
Charleston, SC
Eye Center Of Charleston

5.
William Lee III

349 Folly Rd
Charleston, SC
Carolina Eyecare Physicians Llc

6.
Kristiana Neff

3531 Mary Ader Ave
Charleston, SC
Carolina Cataract And Vision Center

Providers in Charleston Neurosciences Institute

1.Daniel Alfaro Iii Md

3531 Mary Ader Ave
Charleston Sc 29414-5896
Charleston Neurosciences Institute
Ophthalmology

2.Daniel Alfaro Iii Md

9565 Hwy 78 300
Ladson Sc 29456-4118
Charleston Neurosciences Institute
Ophthalmology

3.Mona Camacci

1181 Ribaut Rd
Beaufort Sc 29902-6216
Charleston Neurosciences Institute
Ophthalmology

4.Eric Jablon Md

3531 Mary Ader Ave
Charleston Sc 29414-5896
Charleston Neurosciences Institute
Ophthalmology

5.Michael Johnson Md

3531 Mary Ader Ave
Charleston Sc 29414-5896
Charleston Neurosciences Institute
Ophthalmology

6.John Kerrison Md

3531 Mary Ader Ave
Charleston Sc 29414-5896
Charleston Neurosciences Institute
Ophthalmology

View all 5 members of Charleston Neurosciences Institute medical group